Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis
Science Translational Medicine · 21.02.2024 · 16 (735)
DOI: 10.1126/scitranslmed.adh9751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 21.02.2024. Verfasst von Ronghui Deng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing 100191, P. R. China. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular, Nanoparticles. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic joint disease characterized by progressive degeneration of articular cartilage. A challenge in the development of disease-modifying drugs is effective delivery to chondrocytes. The unique structure of the joint promotes rapid clearance of drugs through synovial fluid, and the dense and avascular cartilage extracellular matrix (ECM) limits drug penetration. Here, we show that poly(lactide- co -glycolic acid) nanoparticles coated in chondrocyte membranes (CM-NPs) were preferentially taken up by rat chondrocytes ex vivo compared with uncoated nanoparticles. Internalization of the CM-NPs was mediated primarily by E-cadherin, clathrin-mediated endocytosis, and micropinocytosis. These CM-NPs adhered to the cartilage ECM in rat knee joints in vivo and penetrated deeply into the cartilage matrix with a residence time of more than 34 days. Simulated synovial fluid clearance studies showed that CM-NPs loaded with a Wnt pathway inhibitor, adavivint (CM-NPs-Ada), delayed the catabolic metabolism of rat and human chondrocytes and cartilage explants under inflammatory conditions. In a surgical model of rat OA, drug-loaded CM-NPs effectively restored gait, attenuated periarticular bone remodeling, and provided chondroprotection against cartilage degeneration. OA progression was also mitigated by CM-NPs-Ada in a canine model of anterior cruciate ligament transection. These results demonstrate the feasibility of using chondrocyte membrane–coated nanoparticles to improve the pharmacokinetics and efficacy of anti-OA drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing 100191, P. R. China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China.
- Beijing Key Laboratory of Sports Injuries, Beijing 100191, P. R. China.
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
- Orthopedic Sports Medicine Center, Beijing Tsinghua Changgung Hospital, Affiliated Hospital of Tsinghua University, Beijing 102218, P. R. China.
ORCID-Profile: Ronghui Deng, Ruifang Zhao, Hao Qin, Zijie Xu, Guangjun Nie, Jia-Kuo Yu
Zitieren
APA
Deng, R., Zhao, R., Zhang, Z., Chen, Y., Yang, M., Lin, Y., Ye, J., Li, N., Qin, H., Yan, X., Shi, J., Yuan, F., Song, S., Xu, Z., Song, Y., Fu, J., Xu, B., Nie, G., & Yu, J. K. (2024). Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis. Science Translational Medicine, 16(735). https://doi.org/10.1126/scitranslmed.adh9751
Vancouver
Deng R, Zhao R, Zhang Z, Chen Y, Yang M, Lin Y, et al. Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis. Science Translational Medicine. 2024;16(735). doi:10.1126/scitranslmed.adh9751
BibTeX
@article{Deng2024,
author = {Deng, Ronghui and Zhao, Ruifang and Zhang, Zining and Chen, Yang and Yang, Meng and Lin, Yixuan and Ye, Jing and Li, Nan and Qin, Hao and Yan, Xin and Shi, Jian and Yuan, Fuzhen and Song, Shitang and Xu, Zijie and Song, Yifan and Fu, Jiangnan and Xu, Bingbing and Nie, Guangjun and Yu, Jia-Kuo},
title = {Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis},
journal = {Science Translational Medicine},
year = {2024},
volume = {16},
number = {735},
doi = {10.1126/scitranslmed.adh9751}
}
EUVIMED